comparemela.com
Home
Live Updates
Fanapt® Shown to be Effective in Bipolar I Disorder in Phase III Clinical Study : comparemela.com
Fanapt® Shown to be Effective in Bipolar I Disorder in Phase III Clinical Study
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today reported positive results in a Phase III clinical study of Fanapt® (iloperidone...
Related Keywords
United States ,
Bulgaria ,
Poland ,
Washington ,
Mihaelh Polymeropoulos ,
Kevin Moran ,
Vanda Pharmaceuticals Inc ,
Twitter ,
Harvard Medical School ,
National Comorbidity Survey Replication ,
Prnewswire Vanda Pharmaceuticals Inc ,
Exchange Commission ,
Head Of Corporate Affairs ,
National Comorbidity Survey ,
Supplemental New Drug Application ,
Young Mania Rating Scale ,
Clinician Global Impression ,
New Drug Application ,
Medical School ,
Comorbidity Survey ,
Biological Psychiatry ,
Boxed Warnings ,
Important Safety Information ,
Increased Mortality ,
Elderly Patients ,
Note Regarding Forward Looking ,
Financial Condition ,
Annual Report ,
Quarterly Reports ,
Current Reports ,
Vice President ,
Chief Financial Officer ,
comparemela.com © 2020. All Rights Reserved.